Androgens and diabetes in men: Results from the Third National Health and Nutrition Examination Survey (NHANES III)

Diabetes Care

Volumn 30, Issue 2, 2007, Pages 234-238

  Selvin, Elizabeth ^a,b   Feinleib, Manning ^a   Zhang, Lei ^c   Rohrmann, Sabine ^d   Rifai, Nader ^e   Nelson, William G ^f,g   Dobs, Adrian ^f   Basaria, Shehzad ^f   Golden, Sherita Hill ^a,b,f   Platz, Elizabeth A ^a,g,h  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Division of Clinical Epidemiology   (Germany)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANDROSTANEDIOL; ANDROSTANOLONE; ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX HORMONE DETERMINATION; TESTOSTERONE BLOOD LEVEL; UNITED STATES;

ADULT; ANDROGENS; BODY MASS INDEX; BODY SIZE; CROSS-SECTIONAL STUDIES; DIHYDROTESTOSTERONE; ESTROGENS; ETHNIC GROUPS; HEALTH SURVEYS; HUMANS; INTERVIEWS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RANDOM ALLOCATION; REFERENCE VALUES; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 33846691958     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1579     Document Type: Article

References (23)

1. Basaria S, Muller DC, Carducci MA, Egan J, Dobs AS: Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 106:581-588, 2006
2. Basaria S, Muller DC, Carducci MA, Egan J, Dobs AS: Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 106:581-588, 2006
3. Swerdlow AJ, Higgins CD, Schoemaker MJ, Wright AF, Jacobs PA, the U.K. Clinical Cytogenetics Group: Mortality in patients with Klinefelter Syndrome in Britain: a cohort study. J Clin Endocrinol Metab 90:6516-6522, 2005
4. American Diabetes Association: Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 29 (Suppl. 1):S43-S48, 2006
5. Bjorntorp P: Metabolic implications of body fat distribution. Diabetes Care 14:1132-1143, 1991
6. Mayes JS, Watson GH: Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 5:197-216, 2004
7. Glass AR, Swerdloff RS, Bray GA, Dahms WT, Atkinson RL: Low serum testosterone and sex-hormone-binding-globulin in massively obese men. J Clin Endocrinol Metab 45:1211-1219, 1977
8. NHANES III data files, documentation, and codebooks, [online]. Available from http://www.cdc.gov/nchs/about/major/nhanes/nh3data.htm. Accessed 9 March 2006
9. Wickings EJ, Nieschlag E: Stability of testosterone and androstenedione in blood and plasma samples. Clin Chim Acta 71:439-443, 1976
10. Comstock GW, Burke AE, Norkus EP, Gordon GB, Hoffman SC, Helzlsouer KJ: Effects of repeated freeze-thaw cycles on concentrations of cholesterol, micronutrients, and hormones in human plasma and serum. Clin Chem 47:139-142, 2001
11. Vermeulen A, Verdonck L, Kaufman JM: A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672, 1999
12. Ding EL, Song Y, Malik VS, Liu S: Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 295:1288-1299, 2006
13. Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT: Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27:1036-1041, 2004
14. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L: Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men: MRFIT Research Group Multiple Risk Factor Intervention Trial. Am J Epidemiol 143:889-897, 1996
15. Barrett-Connor E, Khaw KT, Yen SS: Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol 132:895-901, 1990
16. Oh JY, Barrett-Connor E, Wedick NM, Wingard DL: Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo Study. Diabetes Care 25:55-60, 2002
17. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB: Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care 23:490-494, 2000
18. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86:724-731, 2001
19. Wu FCW, von Eckardstein A: Androgens and coronary artery disease. Endocr Rev 24:183-217, 2003
20. Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH: Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men: a 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol 146:609-617, 1997
21. Gooren LJ: The age-related decline of androgen levels in men: clinically significant? Br J Urol 78:763-768, 1996
22. Gyllenborg J, Rasmussen SL, Borch-Johnsen K, Heitmann BL, Skakkebaek NE, Juul A: Cardiovascular risk factors in men: the role of gonadal steroids and sex hormone-binding globulin. Metabolism 50:882-888, 2001
23. Phillips GB, Pinkernell BH, Jing TY: The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 14:701-706, 1994